---
title: "This Clorox Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294064954.md"
description: "Wall Street analysts downgraded five stocks on Tuesday: Levi Strauss (LEVI) by Wells Fargo, Selective Insurance (SIGI) by BMO, Alpine Income Property Trust (PINE) by Raymond James, Clorox (CLX) by Jefferies, and Progyny (PGNY) by Barclays. Most maintained or adjusted price targets while lowering ratings from bullish to neutral or hold."
datetime: "2026-07-28T12:12:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294064954.md)
  - [en](https://longbridge.com/en/news/294064954.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294064954.md)
generator: "portal-rs"
---

# This Clorox Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Wells Fargo analyst Ike Boruchow downgraded **Levi Strauss & Co** (NYSE:LEVI) from Overweight to Equal-Weight and maintained the price target of $25. Levi Strauss shares closed at $25.53 on Monday. See how other analysts view this stock.
-   BMO Capital analyst Michael Zaremski downgraded **Selective Insurance Group Inc** (NASDAQ:SIGI) from Outperform to Market Perform and maintained the price target of $97. Selective Insurance closed at $92.78 on Monday. See how other analysts view this stock.
-   Raymond James analyst RJ Milligan downgraded **Alpine Income Property Trust Inc** (NYSE:PINE) from Strong Buy to Outperform and maintained the price target of $22. Alpine Income Property shares closed at $20.64 on Monday. See how other analysts view this stock.
-   Jefferies analyst Kaumil Gajrawala downgraded **Clorox Co** (NYSE:CLX) from Buy to Hold and cut the price target from $125 to $98. Clorox shares closed at $97.41 on Monday. See how other analysts view this stock.
-   Barclays analyst Peter Warendorf downgraded **Progyny Inc** (NASDAQ:PGNY) from Overweight to Equal-Weight and raised the price target from $27 to $34. Progyny shares closed at $31.59 on Monday. See how other analysts view this stock.

Considering buying CLX stock? Here’s what analysts think:

*Photo via Shutterstock*

### Related Stocks

- [PGNY.US](https://longbridge.com/en/quote/PGNY.US.md)
- [LEVI.US](https://longbridge.com/en/quote/LEVI.US.md)
- [SIGI.US](https://longbridge.com/en/quote/SIGI.US.md)
- [CLX.US](https://longbridge.com/en/quote/CLX.US.md)
- [PINE.US](https://longbridge.com/en/quote/PINE.US.md)
- [SIGIP.US](https://longbridge.com/en/quote/SIGIP.US.md)
- [PINE-A.US](https://longbridge.com/en/quote/PINE-A.US.md)

## Related News & Research

- [CLX: Highlights include timing solutions, network resilience, and steady FY27 outlook](https://longbridge.com/en/news/298432050.md)
- [Progyny, Inc. $PGNY Position Boosted by WINTON GROUP Ltd](https://longbridge.com/en/news/298575293.md)
- [Progyny director Kevin K. Gordon disposes of 22,000 common shares worth $609,421.30](https://longbridge.com/en/news/298966134.md)
- [Passive income investors are buying 5 well-known high-yield stocks near 52-week lows](https://longbridge.com/en/news/298458317.md)
- [Selective to Present at the 2026 Keefe, Bruyette & Woods Insurance Conference | SIGI Stock News](https://longbridge.com/en/news/298348331.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**